Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published Date:

Abstract

No abstract available for this article.

Authors

  • M Wiesweg
    Department of Medical Oncology, West German Cancer Center; Division of Thoracic Oncology, Ruhrlandklinik; Genome Informatics, Institute of Human Genetics.
  • F Mairinger
    Institute of Pathology, West German Cancer Center.
  • H Reis
    Institute of Pathology, West German Cancer Center.
  • M Goetz
    Institute of Pathology, West German Cancer Center.
  • R F H Walter
    Institute of Pathology, West German Cancer Center.
  • T Hager
    Institute of Pathology, West German Cancer Center.
  • M Metzenmacher
    Department of Medical Oncology, West German Cancer Center.
  • W E E Eberhardt
    Department of Medical Oncology, West German Cancer Center; Division of Thoracic Oncology, Ruhrlandklinik.
  • A McCutcheon
    Department of Medical Oncology, West German Cancer Center.
  • J Köster
    Genome Informatics, Institute of Human Genetics.
  • M Stuschke
    Department of Radiotherapy, West German Cancer Center.
  • C Aigner
    Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik.
  • K Darwiche
    Department of Pulmonary Medicine, Section of Interventional Pneumology, Ruhrlandklinik - University Hospital Essen, University Duisburg-Essen, Essen.
  • K W Schmid
    Institute of Pathology, West German Cancer Center; German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany.
  • S Rahmann
    Genome Informatics, Institute of Human Genetics.
  • M Schuler
    Department of Medical Oncology, West German Cancer Center; Division of Thoracic Oncology, Ruhrlandklinik; German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany. Electronic address: martin.schuler@uk-essen.de.